ripekg:evaluation/RIPEAC2AEB94260D2D014 |
prov:used |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC2AEB94260D2D014 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC2AEB94260D2D014 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:concerns |
ripekg:work/10.1002%2Ffsn3.2806Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS‐C) and mixed (IBS‐M) stool pattern: A randomized, double‐blind clinical trial |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:recruitmentEndDate |
01-2020 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:recruitmentEndDateExtractionRationale |
Methods: 'Fifty-six patients by simple random sampling were recruited from the Soroush Special Clinic of Ahvaz, Iran, between September 2019 and January 2020'; using January 2020 as the recruitment finish date. |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:recruitmentStartDate |
09-2019 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:recruitmentStartDateExtractionRationale |
Methods: 'Fifty-six patients by simple random sampling were recruited from the Soroush Special Clinic of Ahvaz, Iran, between September 2019 and January 2020'; using September 2019 as the recruitment start date. |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
ripe:studyEndDateExtractionRationale |
No explicit study completion date found. |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC2AEB94260D2D014-human-2-2 |
ripekg:study-design-evidence/RIPEAC2AEB94260D2D014 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC2AEB94260D2D014-inspectai-2-2 |